HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatal dural sinus thrombosis associated with heterozygous factor V Leiden and a short activated partial thromboplastin time.

Abstract
Inherited thrombophilia is a risk factor for dural sinus thrombosis (DST). To our knowledge, this is the first description with autopsy findings of a patient with DST associated with heterozygous factor V Leiden and a short activated partial thromboplastin time (aPTT). A 51-year-old woman presented with a 3-day history of headache, nausea, right-sided weakness, and focal motor seizure; she died 3 days after admission. At autopsy, a gross examination showed hemorrhage of bilateral parietal lobes and left primary motor cortex, uncal and tonsillar herniation, and pulmonary embolus of the right upper lobe. A microscopic examination of the brain showed an organizing thrombus in the superior sagittal sinus, diffuse cerebral edema, and extensive venous congestion. Laboratory studies showed heterozygous factor V Leiden by polymerase chain reaction and a very short aPTT of 17 seconds (reference range, 22-30 seconds). The combination of a heterozygous factor V Leiden mutation and a short aPTT may have contributed to the fatal DST in this patient.
AuthorsChristina L Stephan, Karen SantaCruz, Corrie May, Steve B Wilkinson, Mark T Cunningham
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 127 Issue 10 Pg. 1359-61 (Oct 2003) ISSN: 1543-2165 [Electronic] United States
PMID14521455 (Publication Type: Case Reports, Journal Article)
Chemical References
  • factor V Leiden
  • Factor V
Topics
  • Factor V (genetics)
  • Fatal Outcome
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Mutation
  • Partial Thromboplastin Time
  • Sinus Thrombosis, Intracranial (diagnosis, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: